StockData
Supernus, Inc. logo

Supernus, Inc. (SUPN) stock

SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$28.96−0.08 (-0.28%)

Close on Nov 18, 2026Market cap $3.42BP/E 8.1Yield –

Supernus shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Supernus's shares outstanding was 122M at Sep 30, 2026. For fiscal 2025 it was 128M, down 3.8% from the year before. The highest annual figure on record is 152M in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025128M-3.8%
FY2024Dec 31, 2024133M-2.9%
FY2023Dec 31, 2023137M-1.4%
FY2022Dec 31, 2022139M-8.5%
FY2021Dec 31, 2021152M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026122M-5.4%
Q2 FY2026Jun 30, 2026124M-1.6%
Q1 FY2026Mar 31, 2026129M+3.2%
Q4 FY2025Dec 31, 2025131M+0.8%
Q3 FY2025Sep 30, 2025129M-3.0%
Q2 FY2025Jun 30, 2025126M-6.7%
Q1 FY2025Mar 31, 2025125M-8.8%
Q4 FY2024Dec 31, 2024130M–
Q3 FY2024Sep 30, 2024133M–
Q2 FY2024Jun 30, 2024135M–
Q1 FY2024Mar 31, 2024137M–

More Supernus figures

See a number that looks wrong?